Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
Informa PLC | ABOUT US | INVESTOR RELATIONS | TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
informa
  • 0Shopping Cart
Report Store | Pharma intelligence
  • My Account
  • 0
  • $0.00
  • Disease analysis
  • Strategy analysis
  • Company analysis
  • Drug analysis
  • Medtech analysis
  • Opinion & analysis
  • Blogs

Thank-You

You are here: Home > Thank-You
  • Benign Prostatic Hyperplasia and Prostatitis Device-Based Treatments Market
  • Global Diabetes Management Devices Market
  • Global Market for Arthroscopy and Sports Medicine Devices
  • Pain Management Devices Market
  • Pharma Externalization Strategies 2016

Best Selling Products

  • M&A Analysis

    M&A Outlook 2018

    $3,000.00

    PharmaVitae explores the rationale for accelerated dealmaking in 2018, earmarking companies touted for M&A activity, and details 27 targets that potential acquirers should prioritize based on strategic themes, KOL interviews, and physician surveys.

    April 24, 2018
    Find out more

  • Interventional Cardiology Vascular Stents

    $599.00

    The global market for vascular stents is being driven by the increasing prevalence of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually.

    January 25, 2018
    Find out more

  • 2018 Biomedtracker / Meddevicetracker / Datamonitor Healthcare Post-ACC Report

    $599.00

    The American College of Cardiology (ACC) 66th Scientific Session was held in Washington, DC from 17–19 March 2017.

    April 6, 2018
    Find out more

  • Epilepsy KOL Interview – US, West

    $599.00

    A US key opinion leader (KOL) discusses the epilepsy treatment landscape, including new market entrant Epidiolex, and provides their perspective on late-phase pipeline anti-epileptic drugs such as Fintepla.

    February 18, 2019
    Find out more
Recommend this page

Call us on

+1 888 670 8900 : US Toll

+1 908 547 2200 : US

+44 20 337 73737 : UK

+61 2 8705 6968 : Australia

+81 3 6273 4260 : Japan

E-mail us
  • Home
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
Datamonitor Healthcare is part of Pharma intelligence Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Call Back
We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.
By continuing to use the website, you consent to our use of cookies.OkRead more
Scroll to top